Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q1 2024 vs. Q4 2023
How the institutions holding Sunshine Biopharma Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 2.75M | 5.72M | +2.97M (+108.1%) |
| Value | $745.7K | $346.2K | −$399.6K (−53.6%) |
New holders (4)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 87,610 | $5.30K | 0.00% |
| Royal Bank of Canada | 65,000 | $4.00K | 0.00% |
| Two Sigma Investments, LP | 19,196 | $1.16K | 0.00% |
| HRT Financial LP | 18,068 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Sunshine Biopharma Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Armistice Capital, LLC | 2,130,000 | $578.3K |
| Virtu Financial LLC | 23,862 | $6.00K |
| National Bank of Canada | 6,042 | $1.63K |
| Oliver Lagore Vanvalin Investment Group | 1 | $0 |